SYNTHESIS OF C-14 AND H-3 LABELED 6-NITRO-7-SULFAMOYLBENZO[F]QUINOXALIN-2,3-DIONE

被引:4
作者
FOGED, C
JACOBSEN, P
机构
[1] Novo Nordisk Cns-Division, Måløv, DK‐2760, Novo Nordisk Park
关键词
RADIOLABELED 6-NITRO-7-SULFAMOYLBENZO[F]QUINOXALIN-2,3-DIONE; NBQX; GLUTAMATE ANTAGONIST; AMPA;
D O I
10.1002/jlcr.2580310505
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A C-14 labelled form of 6-nitro-7-sulfamoylbenzo[f]quinoxalin-2,3-dione [1] was synthesized in two steps from 1,2-diamino-5-sulfamoylnaphthalene [2] and 30 MCi C-14-oxalic acid. A total of 5.5 mCi was isolated as a yellow solid with a radiochemical purity > 99%. The specific activity was 99 mCi/mmol. A H-3 labelled form of [1] was synthesized in two steps from 10-bromo-7-sulfamoylbenzo-[f]quinoxalin-2-3-dione [4] and tritium gas. The product was isolated with a radiochemical purity of > 98% and a specific activity of 10 Ci/mmol.
引用
收藏
页码:365 / 373
页数:9
相关论文
共 10 条
[1]   DELAYED AMPA RECEPTOR BLOCKADE REDUCES CEREBRAL INFARCTION INDUCED BY FOCAL ISCHEMIA [J].
BUCHAN, AM ;
XUE, D ;
HUANG, ZG ;
SMITH, KH ;
LESIUK, H .
NEUROREPORT, 1991, 2 (08) :473-476
[2]  
BUCHAN AM, 1991, IN PRESS NEUROSCI LE
[3]  
JACOBSEN PK, UNPUB
[4]  
JUDGE ME, 1991, IN PRESS J NEUROSCI
[5]  
KLOCKGETHER T, 1991, IN PRESS ANN NEUROL
[6]  
NELLGARD B, 1991, IN PRESS J CEREB BLO
[7]  
SHEARDOWN M J, 1989, Drugs of the Future, V14, P667
[8]   2,3-DIHYDROXY-6-NITRO-7-SULFAMOYL-BENZO(F)QUINOXALINE - A NEUROPROTECTANT FOR CEREBRAL-ISCHEMIA [J].
SHEARDOWN, MJ ;
NIELSEN, EO ;
HANSEN, AJ ;
JACOBSEN, P ;
HONORE, T .
SCIENCE, 1990, 247 (4942) :571-574
[9]  
SHEARDOWN MJ, 1990, PHARMACOLOGY OF CEREBRAL ISCHEMIA 1990, P245
[10]  
USUKI A, 1989, Patent No. 4889855